Epstein-Barr virus-positive diffuse large B-cell lymphomaNews & Research
9 curated articles for Epstein-Barr virus-positive diffuse large B-cell lymphoma — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Modern rheumatology case reports May 15, 2026
Rapid Progression of Methotrexate-Associated Lymphoproliferative Disorder Presenting with Multiple Pulmonary Masses in rheumatoid arthritis patient: A Case Report.
Lymphoproliferative disorders (LPDs) are relatively rare but serious complications in patients with rheumatoid arthritis (RA) undergoing immunosuppressive therapy. Here, we report a case of methotrexate-associated LPD (MTX-LPD) in a 74-year-old patient with RA who presented with multiple pulmonary n...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- BMC ophthalmology May 1, 2026
Retinal vasculitis as a presenting sign of Epstein-Barr virus positive diffuse large B-cell lymphoma: a case report.
Retinal vasculitis as a presenting sign of Epstein-Barr virus positive diffuse large B-cell lymphoma: a case report.
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Annals of hematology Apr 17, 2026
Low hemoglobin as a novel prognostic biomarker in EBV-positive diffuse large B-cell lymphoma patients: a clinical feature analysis of 99 cases from Zhejiang, Southeast China.
Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is a rare and clinically aggressive subtype of DLBCL, distinguished by its notably unfavorable prognosis. The clinical characteristics of this entity remain insufficiently characterized in the Chinese population. This study retros...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Cell death & disease Mar 26, 2026
Long noncoding RNA ADEI/miR-93-3p/STAT3 axis promotes Epstein-Barr virus-positive diffuse large B-cell lymphoma progression and immune evasion through regulating the PD-1/PD-L1 checkpoint.
Epstein-Barr virus (EBV) is an important pathogenic factor of lymphoma; EBV+diffuse large B-cell lymphoma (DLBCL) has a worse prognosis with standard chemotherapy than EBV-DLBCL. Long noncoding (Lnc)-RNAs are key regulators of cancer pathways and biomarkers of disease. As natural protective carriers...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Frontiers in medicine Mar 2, 2026
Case Report: Rare pulmonary infection and cytomegalovirus retinitis revealed a case of lymphoma.
Recurrent cytomegalovirus retinitis (CMVR) and rare opportunistic pulmonary infections may be the initial manifestations of underlying immunodeficiency caused by occult hematologic malignancy. Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified (EBV + DLBCL-NOS) is an ...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Annals of African medicine Feb 23, 2026
Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma Presenting as Pyrexia of Unknown Origin Complicated by Paraneoplastic Neurological Syndrome.
Chikungunya virus (CHIKV) infection is an arboviral disease transmitted by Aedes mosquitoes, typically presenting with fever, rash, and polyarthralgia. Neurological complications such as meningitis are rare and more often seen in neonates and immunocompromised individuals. Hepatic involvement is als...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Hematology (Amsterdam, Netherlands) Feb 11, 2026
Characteristics and prognosis of Epstein Barr virus-positive diffuse large B-cell lymphoma: a retrospective, single-center study.
To analyze the clinical characteristics and prognosis of Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV + DLBCL) in a Chinese cohort. Fifty-seven EBV + DLBCL patients (diagnosed between 2013 and 2020) and 228 EBV-negative DLBCL (EBV - DLBCL) controls were included. Differences were c...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Case reports in hematology Feb 9, 2026
Breast Implant-Associated Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.
Breast implant-associated diffuse large B-cell lymphoma (BIA-DLBCL) is an extremely rare entity, often misdiagnosed as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Unlike BIA-ALCL, which is a T-cell neoplasm, BIA-DLBCL shows B-cell immunophenotype and is frequently associated...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
- Annals of plastic surgery Jan 23, 2026
Bilateral Breast Implant-Associated Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review.
Breast implant associated anaplastic large cell lymphoma with a single T cell clone is an uncommon complication especially related to implants with a textured surface. Moreover, there are few reports of breast implant-associated Epstein-Barr virus-positive diffuse large B-cell lymphoma (BIA-EBV-posi...
Why it matters: Recent peer-reviewed research on Epstein-Barr virus-positive diffuse large B-cell lymphoma that may be relevant for patients and caregivers.
More on Epstein-Barr virus-positive diffuse large B-cell lymphoma
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.